Delivery Order SPE2DB22D3301-SPE2DB25FX9BW
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,490.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 50-1,000 mg tablet prescription medication, with an ultimate completion date of July 29, 2024. This is a firm fixed price delivery order contract, and there is no set-aside designation indicated. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous...
This federal contract award, valued at $1,352.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-500 MG TABLET 180S, a medication used for the treatment of diabetes. The contract is a firm fixed-price Delivery Order and has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the...
This federal contract award, valued at $9,094.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide JANUMET XR 50-1,000 mg tablets. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued up to $999,999,999.00 and runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division for the delivery of JANUMET XR 50-1,000 mg tablets in quantities of 180. The $36,954.42 fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $2,428.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets in quantities of 30s. The contract is a Firm Fixed Price Delivery Order with a completion date of June 7, 2023. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This federal contract award, valued at $1,563.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a drug used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. The award does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,226.94, is a firm fixed-price delivery order with an ultimate completion date of August 2, 2023. It was awarded on August 1, 2023, and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.96 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $3,612.11, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 25, 2024 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $5,553.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUMET XR 100-1,000 MG TABLET 90S. The contract has a completion date of May 22, 2024 and is structured as a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...